Rachel Reeves has been warned that firms face a "make-or-break moment" at next month's budget. The British Chamber of Commerce (BCC) urged the chancellor, who is widely expected to announce tax hikes ...

A BYD assembly plant, joining two other planned factories in Hungary and Turkey, would be a significant boost for the ...

Mexico’s state oil giant Pemex is fast-tracking plans to boost output by reopening nearly 400 idle onshore wells, partnering with private firms through service contracts to tackle wells previously ...

Alpha Modus (NASDAQ:AMOD), a technology provider specializing in AI-driven retail solutions, has filed a patent infringement lawsuit against Lowe’s Companies (NYSE:LOW), Investing.com has learned.

The outages began on Monday afternoon, according to the monitoring website DownDetector, which reported more than 130,000 issues with Vodafone connections. The company has more than 18 million UK ...

The telecoms giant said on Monday afternoon that it is trying to fix a major issue which has impacted its broadband, 4G and ...

Morgan Stanley raised its price target on Rocket Lab USA to $68 from $20, saying the launch provider is emerging as a publicly traded alternative to Elon Musk’s SpaceX and should benefit from strong ...

ABB announces collaboration with NVIDIA The collaboration will create new power solutions for future gigawatt-scale data centers. Cary, North Carolina, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Collaboration ...

Upexi (UPXI) recently shared its latest approach to digital asset strategies at the Digital Asset Treasury Showcase. This offered investors a fresh perspective on its evolving investment direction, ...

Presentation will cover two-year clinical efficacy, immunogenicity and safety dataData will be presented at an oral session on October 17, 2025, followed by a webinar on October 22, 2025, providing ...

Quilter's fair value estimate has seen a small but notable increase, rising from £1.77 to £1.81 per share as analysts revise their outlook. This change comes amid growing optimism from both bullish ...

This data-driven resource analyzes 1,775 clinical-stage deals (Phase I–III) with headline values, upfronts, milestones, and royalty ranges, plus links to deal records and SEC-filed contracts where ...